InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) announced that the ninth patient implanted with the Neuro-Spinal Scaffold™ in the INSPIRE study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE